CBER Approvals In 2014
Executive Summary
FDA transferred review of most therapeutic biologics to the Center for Drug Evaluation and Research in 2003. The Center for Biologics Evaluation & Research continues to review other biologics, including vaccines, cellular products, antitoxins and immunoglobulins. Thus far in 2014, the agency has cleared five such products.